This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

Pfizer at Cowen and Company Health Care Conference - Final  -  24 Mar 2008
Insurance News Net (press release),While hepatocellular carcinoma is not a big tumor type, say, in Western Europe or the US, it is a very significant -- has a very high prevalence in Asia,

What Change Does Prokineticin 2/Bv8 Have In Human Hepatocellular ...  -  Mar 18, 2008
Science Daily (press release)The angiogenic potential of these two peptides during human hepatocellular carcinoma progression was evaluated. These findings show, that only,

Nexavar® Added to Treatment Guidelines for Hepatocellular Carcinoma  -  Mar 17, 2008
Cancer Consultants,Nexavar® (sorafenib) has been added to the list of treatment options for patients with hepatocellular carcinoma (HCC) who are not eligible for a liver

Sorafenib Added to Guidelines for Treatment of Hepatocellular ...  -  Mar 12, 2008
DG NewsIt appears to be, for the first time, an effective systemic treatment for hepatocellular carcinoma," said Al B. Benson III, MD, Professor of Medicine,

Ablation Therapy Guided by Contrast-Enhanced Sonography with ...  -  Feb 26, 2008
Journal of Ultrasound in Medicine (subscription)We examined 85 patients with 108 hepatocellular carcinoma lesions that were identified as hypervascular by multidetector-row computed tomography by using

Surveillance for Hepatocellular Carcinoma in Patients with ...  -  Feb 28, 2008
Cancer Consultants,The role of early diagnosis has been stressed in the success of liver transplantation for hepatocellular carcinoma, but little has been reported about

High intake of flavonoids linked to lower risk of liver cancer  -  Mar 23, 2008
Food Consumer,The study found flavone intake mostly from spinach and peppers was inversely associated with viral or non-viral hepatocellular carcinoma.

Family Of Liver Cancer Genes Discovered  -  Feb 27, 2008
Science Daily (press release)...and colleagues discovered in a mouse model that the loss of one specific gene (Iqgap2) in this family causes Hepatocellular carcinoma (HCC).

Contrast-Enhanced Ultrasonography of Hepatic Metastasis of ...  -  Mar 21, 2008
Journal of Ultrasound in Medicine (subscription)12 According to prior studies, 11 our HPC had the same enhancement characteristics as other hypervascular liver tumors, including hepatocellular carcinoma

Liver Cancer – Signs and Symptoms of Liver Cancer  -  Mar 17, 2008
Los Angeles Chronicle,Liver cancer (hepatocellular carcinoma) is a cancer arising from the liver. It is also known as primary liver cancer or hepatoma.

Surgery Can Be Effective Monotherapy for Pancreatic Metastases ...  -  Mar 17, 2008
DG News...melanoma (n = 3), colon (n = 2), breast (n = 1), hepatocellular carcinoma (n = 1), seminoma (n = 1), and Langerhans cell histiocytosis (n = 1).

Laser Ablation Safe, Effective for Small Hepatocellular Tumors  -  Mar 13, 2008
Cancerpage.com,NEW YORK MAR 13, 2008 (Reuters Health) - Percutaneous laser ablation is a safe and effective treatment for small hepatocellular carcinoma (HCC) nodules,

Family of liver cancer genes found  -  Mar 1, 2008
Times of India,...and colleagues, who discovered in a mouse model that losing one specific gene (Iqgap2) in this family may lead to Hepatocellular carcinoma (HCC).

Bayer and Onyx Provide Update on Phase III Trial of Nexavar® in ...  -  Mar 5, 2008
PR-USA.net (press release),In Europe, Nexavar is approved for the treatment of hepatocellular carcinoma and for the treatment of patients with advanced renal cell carcinoma (RCC) who

Guidelines Support Ablation Techniques for Unresectable Liver ...  -  Mar 12, 2008
DG NewsDr. Benson said that ablation procedures in localised hepatocellular carcinoma could employ several techniques, including radiofrequency ablation,

Progen Announces Commencement of Global Phase 3 Study for PI-88 in ...  -  Mar 11, 2008
CNNMoney.com (press release)About the phase 3 study: The phase 3 study investigating PI-88 as a post- resection treatment for hepatocellular carcinoma (HCC, primary liver cancer)

Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL ...  -  Mar 20, 2008
Earthtimes,HCV infection is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Approximately 170 million people are infected with HCV

Liver Cancer Survival Predicted by MicroRNA Molecules  -  Mar 20, 2008
TopCancerNews.com,Liver cancer, or hepatocellular carcinoma, is the third most common cause of cancer death worldwide, killing some 662000 people in 2005, according to the

How to defeat a virus  -  Mar 19, 2008
Express Healthcare Management,Hep-C is the most common cause of hepatocellular carcinoma and the primary reason for liver transp-lantations among adults. All drugs have side-effects and

BioSphere Medical Highlights Scheduled Presentations and Abstracts ...  -  Mar 14, 2008
Business Wire (press release),...agents doxorubicin or epirubicin for transcatheter arterial chemoembolization, or TACE, in patients with unresectable hepatocellular carcinoma, or HCC.

Metabasis Therapeutics Reports on 2007 Financial Results, Company ...  -  Mar 17, 2008
Business Wire (press release),The Company completed a Phase 1/2 clinical trial for MB07133, its product candidate for the treatment of hepatocellular carcinoma (HCC), or primary liver

The Vanishing Nonforensic Autopsy  -  Feb 27, 2008
New England Journal of Medicine (subscription),...presented with decompensated liver failure from presumed alcoholic cirrhosis but proved at autopsy to have widely metastatic hepatocellular carcinoma.

Chemokine Therapeutics Receives Approval From Health Canada to ...  -  Mar 5, 2008
CNNMoney.comHepatocellular carcinoma (HCC), the most common form of liver cancer, occurs more often in males than females and is most common in people over 50 years of

Celsion Commences Global Phase III Study for Primary Liver Cancer  -  Mar 16, 2008
PR-Inside.com (Pressemitteilung),Doxorubicin) in Combination with Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma (HCC).

Progen Announces Commencement of Global Phase 3 Study for PI-88 in ...  -  Mar 11, 2008
SunHerald.com,...for primary liver cancer (hepatocellular carcinoma, HCC) following curative resection with the first patient having been randomized onto the study.

Conclusion of Co-Development and Co-Marketing Agreement on Z-338 ...  -  Mar 10, 2008
PharmaLive.com (press release),Furthermore, in the same area, Z-206 for inflammatory bowel disease, Z-360 for pancreatic cancer and Z-208 for hepatocellular carcinoma are under

Treatment of the HBV-Infected Patient: When to Start, When to Stop ...  -  Feb 27, 2008
Medscape (subscription)Chronic hepatitis B virus (HBV) infection is a potentially serious disease that can lead to cirrhosis, end-stage liver disease, and hepatocellular carcinoma

Biocompatibles International plc - Research Update  -  Mar 5, 2008
Trading Markets (press release),The first product into clinical trials was the Drug-Eluting Bead, delivering doxorubicin for the treatment of Hepatocellular Carcinoma (HCC).

The Promise of Locoregional Radiopharmaceutical Therapy: Will It ...  -  Mar 5, 2008
Journal of Nuclear Medicine (subscription)...locoregional adjuvant therapy with radiolabeled lipiodol increases disease-free and perhaps overall survival in patients with hepatocellular carcinoma.

Liver Phase I Abstract Presented at 8th World Congress of IHPBA  -  Feb 29, 2008
Genetic Engineering News (press release),We now look forward to launching our global Phase III study of ThermoDox for hepatocellular carcinoma in the immediate near-term.

Relief for liver cancer patients  -  Feb 28, 2008
GulfNews,Even with minimal reported cases in the UAE with Hepatocellular carcinoma (HCC), a primary malignancy and cancer of the liver, latest statistics indicate

ImClone Systems enrols first patient in clinical trial of IMC ...  -  Feb 26, 2008
News-Medical.net,...the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).

Nexavar trial ended by Bayer and Onyx  -  Feb 18, 2008
Pravda,It has also received "Fast Track" designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since

Phase 3 Trial of Sorafenib in Patients With Non-Small-Cell Lung ...  -  Feb 19, 2008
DG NewsIn Europe, sorafenib is approved for the treatment of hepatocellular carcinoma and for the treatment of patients with advanced renal cell carcinoma (RCC)

Infections Causing Human Cancer  -  Feb 19, 2008
Journal of American Medical Association (subscription),...and Hodgkin disease; of hepatitis B and C viruses in hepatocellular carcinoma; and of the relationship between papillomaviruses and cervical cancer.

Sorafenib Plus Doxorubicin May Offer Better Time to Progression ...  -  Feb 8, 2008
DG News..."This trial supports the growing body of evidence of the activity of sorafenib in advanced hepatocellular carcinoma," Dr. Abou-Alfa noted.

Patients at Risk for Liver Cancer Should Be Screened With ...  -  Jan 27, 2008
DG NewsActive hepatitis C virus infection with or without alcohol use accounts for most of the hepatocellular carcinoma in the United States.

BioSphere gets OK to sell Embosphere in China  -  Jan 28, 2008
Bizjournals.com,About half the world's annual cases of hepatocellular carcinoma occur in China, and microspheres can be used as part of a treatment, the company said in a

Proteomic profiling helps identify patients with liver cancer  -  Feb 4, 2008
Medicexchange,Dr. Afdhal of Harvard Institutes of Medicine and colleagues examined sera from 41 patients with hepatocellular carcinoma and 51 with hepatitis C cirrhosis.

Bayer extends product portfolio for liver cancer patients in Japan  -  Jan 24, 2008
The FINANCIAL,In the US, Nexavar is approved for the treatment of patients with unresectable hepatocellular carcinoma (HCC). Nexavar is approved in more than 30 countries

Perlegen, SC Liver Research Consortium to Study Genetics Behind ...  -  Feb 19, 2008
GenomeWeb News (subscription),On the other hand, hepatitis C itself can lead to other serious complications such as liver cirrhosis or scarring and hepatocellular carcinoma,

Dr. Mehta: Hepatoma: Liver cancer -- new advances  -  Jan 28, 2008
Waukegan News Sun,Biopsy of the liver revealed cancer called hepatocellular carcinoma. Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide,

Bayer/Onyx Pharmaceuticals: Nexavar approved for kidney cancer in ...  -  Jan 28, 2008
Trading Markets (press release),Nexavar is also approved in both the US and EU for advanced hepatocellular carcinoma. In September 2007, a new drug application for Nexavar was filed for

Nexavar Approved for the Treatment of Kidney Cancer in Japan  -  Jan 28, 2008
The FINANCIAL,In September 2007, an additional application for the treatment of hepatocellular carcinoma (HCC) was filed. Japanese authorities recently granted priority

First New Drug Therapy in 30 Years Offers Hope to Liver Cancer ...  -  Feb 4, 2008
Canada NewsWire (press release),About Liver Cancer Hepatocellular carcinoma is the most common form of liver cancer and is responsible for approximately 90 per cent of the primary

Delcath Systems to Host Conference Call to Provide Corporate Update  -  Feb 13, 2008
FOXBusinessThe Delcath Systemis currently being tested in Phase III and Phase II clinical trials for the treatment of hepatocellular carcinoma and metastatic tumors in

SciClone and Sigma-Tau Report Promising Interim Results From Phase ...  -  Feb 11, 2008
CNNMoney.com...infected patients can develop serious complications including cirrhosis of the liver, liver failure and hepatocellular carcinoma or liver cancer.

ASCO GI: HCV Infection Does Not Blunt Sorafenib Response in Liver ...  -  Jan 28, 2008
MedPage Today,Explain to interested patients that this study suggests that sorafenib (Nexavar) may extend survival in patients with advanced hepatocellular carcinoma

BioSphere Medical Receives Market Clearance to Sell Embosphere ...  -  Jan 28, 2008
Business Wire (press release),In China, the annual incidence of hepatocellular carcinoma (HCC or primary liver cancer) is approximately 350000, roughly half of the total worldwide

Excess Body Weight Raises Cancer Risk  -  Feb 15, 2008
Cancerpage.com,...fatty liver disease for hepatocellular carcinoma, and the contribution of abdominal obesity to gastro-oesophageal reflux for esophageal adenocarcinoma."

Accelerated Community Oncology Research Network, Inc. (ACORN ...  -  Feb 14, 2008
Earthtimes,Based on the currently approved US package insert for the treatment of patients with unresectable hepatocellular carcinoma, hypertension may occur early in

China-AsiaStocks.com Reports on Healthcare Opportunities in China ...  -  Feb 4, 2008
FOXBusiness...pharmaceutical and healthcare industry analysts predict that the Chinese hepatocellular carcinoma (HCC; the most prevalent type of primary liver cancer)

UPI NewsTrack Health and Science News  -  Feb 13, 2008
United Press International...said the technique, called radioembolization, is being used for the first time in patients with hepatocellular carcinoma, or primary liver cancer.

New Jefferson trial to test radiation-emitting beads against ...  -  Feb 13, 2008
Science Centric,...that has spread to the liver, is being studied in patients with hepatocellular carcinoma, or primary liver cancer (cancer that originates in the liver).

Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented ...  -  Feb 13, 2008
PR Newswire (press release),In the interim, our phase 3 study in the adjuvant hepatocellular carcinoma setting is expected to begin recruitment shortly.

Liver cancer drug raises blood pressure  -  Jan 29, 2008
Tehran Times,...kidney cancer and in 2007 to treat the most common form of liver cancer that can't be surgically removed (unresectable hepatocellular carcinoma or HCC).

Kidney And Liver Cancer Drug Raises High Blood Pressure Risk  -  Jan 25, 2008
Medical News Today,...in patients with advanced renal-cell carcinoma (RCC, the most common form of kidney cancer) and hepatocellular carcinoma, or primary liver cancer.

How to defeat a virus  -  Feb 7, 2008
Express Pharma,Hep-C is the most common cause of hepatocellular carcinoma and the primary reason for liver transplantations among adults. All drugs have side-effects and

More News related to Press Releases  -  Feb 6, 2008
StreetInsider.com (subscription),The cancers included Kaposi's sarcoma, lymphoma, squamous cell carcinoma, hepatocellular carcinoma and anal cancer. Most subjects had other risk factors for

microRNAs may predict survival liver cancer patients  -  Feb 1, 2008
Thaindian.com,Liver cancer, also known as hepatocellular carcinoma, is the third most common cause of cancer death worldwide, killing some 662000 people in 2005,

Molecules may help predict survival in liver cancer  -  Jan 31, 2008
HULIQ,Liver cancer, or hepatocellular carcinoma, is the third most common cause of cancer death worldwide, killing some 662000 people in 2005, according to the

BioSphere Medical Reports 2007 Fourth Quarter and Year-End ...  -  Jan 30, 2008
Trading Markets (press release),The receipt of CE Mark approval for Transarterial Chemoembolization (TACE) of Hepatocellular Carcinoma (HCC) using HepaSphere(TM) Microspheres and

BioSphere to Market Microspheres in China  -  Jan 30, 2008
OneMedPlace,...the opportunity for hepatocellular carcinoma (HCC or primary liver cancer) treatment represents roughly half of the total worldwide, with an annual

Delcath and Aethlon Medical Sign Collaboration Agreement to ...  -  Jan 30, 2008
Business Wire (press release),The Delcath System is currently being tested in Phase III and Phase II clinical trials for the treatment of hepatocellular carcinoma and metastatic tumors

BioSphere to Sell Embosphere Microspheres in China  -  Jan 28, 2008
FDA news (subscription),The annual incidence of hepatocellular carcinoma in China is approximately 350000 — roughly half of the total worldwide incidence.

BioSphere Medical Wins Market Clearance To Sell Embosphere ...  -  Jan 28, 2008
RTT News,...who have and are being treated for benign and malignant hypervascularized tumors, such as uterine fibroids and hepatocellular carcinoma, respectively.

Mass spectrometry enhances proteomic profiling for diagnosing ...  -  Jan 24, 2008
BioOptics World,Over a single decade, the incidence of liver cancer (hepatocellular carcinoma) increased from 1.8 to 2.5 per 100000 patients, in large part due to a rise in

Delcath System Gains Significant Exposure Through Presentations at ...  -  Jan 24, 2008
Business Wire (press release),It is currently being tested in Phase II and III clinical trials for the treatment of hepatocellular carcinoma and metastatic tumors in the liver,

Bayer’s Liver Cancer, Nexavar Raises Blood Pressure  -  Jan 24, 2008
eFluxMedia...cancer and in 2007 for treating the most common form of liver cancer that can’t be surgically removed (unresectable hepatocellular carcinoma or HCC).

Bayer pulls Leukine from US, positive Nexavar news in Japan  -  Jan 24, 2008
Pharma Times (subscription),Japan has the second largest population of liver cancer patients in the world, the majority of which suffer from hepatocellular carcinoma; the indication

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.